ephedrine has been researched along with Obesity in 112 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 39 (34.82) | 18.7374 |
1990's | 38 (33.93) | 18.2507 |
2000's | 26 (23.21) | 29.6817 |
2010's | 7 (6.25) | 24.3611 |
2020's | 2 (1.79) | 2.80 |
Authors | Studies |
---|---|
Bernardini, R; Burgaletto, C; Cantarella, G; Cortinovis, M; Di Mauro, R; Frara, S; Giustina, A; Munafò, A; Perico, N; Remuzzi, G | 1 |
An, HJ; Cominguez, DC; Jin, JS; Kim, HJ; Kim, SY; Koh, DJ; Lim, YW; Park, YB; Park, YJ | 1 |
Fujioka, K; Greenway, FL; Liu, AG; Smith, SR | 1 |
Bailey, D; Barton, J; Bickett, M; Brown, RH; Castellino, S; Elangbam, CS; Faber, C; Gates, L; Hagerty, L; Jordan, H; Kimbrough, C; Peterson, RA; Sola, M; Wagner, DS; Zhu, ZJ | 1 |
Anderson, MJ; Bertovic, DA; Carey, AL; Cherk, MH; Duffy, SJ; Eikelis, N; Formosa, MF; Kalff, V; Kingwell, BA; Lambert, GW; Pajtak, R; Van Every, B | 1 |
Badmaev, V; Stohs, SJ | 1 |
Bray, GA; Greenway, FL | 1 |
Kaplan, LM | 1 |
Bailey, D; Barton, J; Brown, RH; Cariello, N; Clifton, L; Durrant, JR; Elangbam, CS; Faber, CA; Harrington, W; Jordan, H; Kimbrough, C; Milliken, T; Slocum, N; Yoon, L | 1 |
Bertovic, D; Carey, AL; Cherk, MH; Duffy, SJ; Eikelis, N; Formosa, MF; Kalff, V; Kingwell, BA; Lambert, GW; Van Every, B | 1 |
Greenway, FL | 1 |
Stricker, BH; van der Hooft, CS | 1 |
Richelsen, B | 2 |
Astrup, AV | 1 |
von Eyben, FE | 1 |
Riffel, K | 1 |
Abourashed, EA; El-Alfy, AT; Khan, IA; Walker, L | 1 |
JORES, A; LOOS, M; SPIEGELBERG, U | 1 |
NAGEL, V | 1 |
BENDORF, G | 1 |
RHEINLANDER, AP; WEILER, P | 1 |
SUTTINGER, H | 1 |
KUPERSMITH, IH | 1 |
Allison, DB; Baker, BA; Coffey, CS; Steiner, D | 1 |
Balderson, DE; Brouwer, KL; Lancaster, ME; Ng, C; Paulik, MA; Persky, AM; Song, MH | 1 |
Ingerslev, J; Mørk, A; Svendsen, TL | 1 |
Joyal, SV | 1 |
Gettys, T; Hughes, TA; Smith, SR; Stentz, F | 1 |
Kovacs, EM; Mela, DJ | 1 |
Blackburn, G; DeWald, T; Donahue, MP; Khaodhiar, L | 1 |
Diepvens, K; Westerterp, KR; Westerterp-Plantenga, MS | 1 |
Lächler, H; Mallach, HJ; Pedal, I | 1 |
Bukowiecki, L; Follea, N; Jahjah, L | 1 |
Fletcher, HP; Sandage, BW | 1 |
Dulloo, AG; Miller, DS | 6 |
Arch, JR; Thurlby, PL; Wilson, S | 1 |
Evans, E; Massoudi, M; Miller, DS | 1 |
Hansen, G; Lehnschau, A; Lumholtz, IB; Lund, B; Spellerberg, S; Thorsteinsson, B; Wamberg, T | 1 |
Bidstrup, B; Hansen, PW; Helles, A; Kaern, M; Petersen, KP; Roed, P | 1 |
Hey, H; Juhl, E; Larsen, S; Malchow-Møller, A; Quaade, F; Stokholm, KH | 2 |
Danø, P; Draeby, N; Hansen, SH; Jensen, KB; Kanstrup, J | 1 |
Issmeier, G; Muth, H | 1 |
Bemis, KG; McKee, MM; Yen, TT | 1 |
Krauth, J | 1 |
Astrup, A; Buemann, B; Christensen, NJ; Marckmann, P | 1 |
Astrup, A; Breum, L; Quaade, F; Toubro, S | 1 |
Ahlstrøm, F; Breum, L; Frimodt-Møller, J; Pedersen, JK | 1 |
Dulloo, AG; Stock, MJ | 1 |
Dulloo, AG | 2 |
Geissler, CA | 1 |
Molnár, D | 1 |
Casimirri, F; Pasquali, R | 1 |
Astrup, AV; Breum, L; Quaade, F; Toubro, S | 1 |
Daly, PA; Dulloo, AG; Krieger, DR; Landsberg, L; Young, JB | 1 |
Malecka-Tendera, E | 1 |
Astrup, A; Christensen, NJ; Nielsen, B; Samuelsen, P; Wengholt, H | 1 |
Kondo, M; Sakane, N; Umekawa, T; Wakabayashi, Y; Yoshida, T | 1 |
Geissler, CA; Horton, TJ | 2 |
Atkinson, RL; Blank, RC; Loper, JF; Lutes, RA; Schumacher, D | 1 |
Astrup, A; Breum, L; Toubro, S | 1 |
Hartleb, M; Janusz, M; Karpel, E; Nowak, A; Waluga, M | 1 |
Colman, RJ; Kemnitz, JW; Ramsey, JJ; Swick, AG | 1 |
Borrell, L; Foreyt, JP; Haddock, CK; Poston, WS | 1 |
Astrup, A; Lundsgaard, C | 1 |
Franklin, QJ | 1 |
Greenway, F; Herber, D; Morales, S; Raum, W | 1 |
Bray, GA; Greenway, FL; Rood, JC; Ryan, DH; Smith, SR; Tucker, EW | 1 |
Chantre, P; Dulloo, AG; Girardier, L; Seydoux, J; Vandermander, J | 1 |
Bray, GA | 1 |
Erhardt, E; Jeges, S; Molnár, D; Török, K | 1 |
DeLany, JP; Greenway, FL; Raum, WJ | 1 |
Astrup, A | 2 |
Dyck, DJ | 1 |
Czupryniak, L; Drzewoski, J | 1 |
Spake, A | 1 |
Bruzzi, A; Tormey, WP | 1 |
Hardy, M; Shekelle, P | 1 |
Massoudi, M; Miller, DS | 1 |
Stauffacher, W | 1 |
Bortoluzzi, L; Casimirri, F; Grossi, G; Melchionda, N; Morselli Labate, AM; Pasquali, R; Raitano, A; Stefanini, C | 1 |
Astrup, A; Breum, L; Hein, P; Quaade, F; Toubro, S | 2 |
Astrup, A; Christensen, NJ; Quaade, F; Toubro, S | 1 |
Dulloo, AG; Girardier, L; Seydoux, J | 1 |
Astrup, A; Buemann, B; Christensen, NJ; Quaade, F; Thorbek, G; Toubro, S; Victor, OJ | 1 |
Jonderko, K; Kucio, C | 1 |
Adamczak, D; Jonderko, K; Kucio, C | 1 |
Henningsen, NC; Jaedig, S | 1 |
Daly, PA; Dulloo, AG; Krieger, DR; Landsberg, L; Ransil, BJ; Young, JB | 1 |
Dulloo, AG; Flier, JS; Lowell, BB; Napolitano, A; Rosen, BS; Spiegelman, BM; Usher, P | 1 |
Englert, ME; Warren, R; Zgourides, GD | 1 |
Buck, CL; Tulp, OL | 1 |
Balestra, V; Besteghi, L; Cesari, MP; Melchionda, N; Pasquali, R | 1 |
Cesari, MP; Labo, G; Melchionda, N; Pasquali, R; Raitano, A; Stefanini, C | 1 |
Bailey, CJ; Flatt, PR; Thornburn, CC | 1 |
Miller, DS | 1 |
Baraldi, G; Cesari, MP; Melchionda, N; Pasquali, R; Raitano, A; Stefanini, C; Zamboni, M | 1 |
Astrup, A; Christensen, NJ; Lundsgaard, C; Madsen, J | 1 |
Sapeika, N | 1 |
Hunecke, I; Reuter, W | 1 |
21 review(s) available for ephedrine and Obesity
Article | Year |
---|---|
In search of an ideal drug for safer treatment of obesity: The false promise of pseudoephedrine.
Topics: Alkaloids; Ephedra sinica; Ephedrine; Humans; Obesity; Pseudoephedrine | 2021 |
A Review of Natural Stimulant and Non-stimulant Thermogenic Agents.
Topics: Caffeine; Capsaicin; Central Nervous System Stimulants; Chlorogenic Acid; Ephedrine; Humans; Obesity; Overweight; Synephrine; Tea; Thermogenesis | 2016 |
Pharmacologic therapies for obesity.
Topics: Anti-Obesity Agents; Appetite Depressants; Bariatric Surgery; Benzazepines; Bupropion; Cyclobutanes; Ephedrine; Fenfluramine; Humans; Lactones; Naltrexone; Obesity; Orlistat; Phentermine; Weight Gain; Weight Loss | 2010 |
The safety and efficacy of pharmaceutical and herbal caffeine and ephedrine use as a weight loss agent.
Topics: Aminophylline; Animals; Caffeine; Ephedrine; Humans; Obesity; Plant Preparations; Theophylline; Weight Loss | 2001 |
Bad news for dieters: a focus on ephedrine.
Topics: Adverse Drug Reaction Reporting Systems; Appetite Depressants; Consumer Product Safety; Ephedrine; Humans; Obesity; Plant Preparations; United States; United States Food and Drug Administration | 2003 |
Ephedra in perspective--a current review.
Topics: Central Nervous System Stimulants; Dietary Supplements; Ephedra; Ephedrine; Humans; Obesity; Phytotherapy; Plant Components, Aerial; Plant Extracts | 2003 |
A perspective on the current strategies for the treatment of obesity.
Topics: Anti-Obesity Agents; Bariatrics; Chromium; Citrates; Cyclobutanes; Energy Intake; Ephedrine; Exercise Therapy; Garcinia cambogia; Herbal Medicine; Humans; Lactones; Linoleic Acids, Conjugated; Obesity; Orlistat; Phytotherapy; Pyruvic Acid | 2004 |
Metabolically active functional food ingredients for weight control.
Topics: Adipose Tissue; Animals; Body Weight; Caffeine; Calcium, Dietary; Capsaicin; Diet; Diglycerides; Ephedrine; Humans; Linoleic Acids, Conjugated; Obesity; Tea; Triglycerides | 2006 |
Pharmacological and surgical treatments for obesity.
Topics: Anti-Obesity Agents; Anticholesteremic Agents; Antidepressive Agents, Second-Generation; Appetite Depressants; Bariatric Surgery; Caffeine; Dietary Supplements; Enzyme Inhibitors; Ephedrine; Ghrelin; Humans; Hypoglycemic Agents; Life Style; Obesity; Peptide Hormones; Serotonin Agents | 2006 |
Obesity and thermogenesis related to the consumption of caffeine, ephedrine, capsaicin, and green tea.
Topics: Animals; Body Weight; Caffeine; Capsaicin; Central Nervous System Stimulants; Energy Metabolism; Ephedrine; Humans; Obesity; Tea; Thermogenesis | 2007 |
Ephedrine, xanthines and prostaglandin-inhibitors: actions and interactions in the stimulation of thermogenesis.
Topics: Animals; Body Temperature Regulation; Drug Combinations; Drug Synergism; Ephedrine; Humans; Obesity; Prostaglandin Antagonists; Xanthines | 1993 |
Clinical aspects of ephedrine in the treatment of obesity.
Topics: Body Composition; Caffeine; Diet, Reducing; Energy Metabolism; Ephedrine; Female; Humans; Male; Obesity | 1993 |
Combined drug treatment of obesity.
Topics: Adrenergic Agents; Appetite Depressants; Benzocaine; Drug Therapy, Combination; Ephedrine; Fenfluramine; Humans; Obesity; Phentermine; Phenylpropanolamine; Serotonin Agents | 1995 |
Pharmacological and clinical studies of ephedrine and other thermogenic agonists.
Topics: Appetite Depressants; Body Temperature Regulation; Caffeine; Ephedrine; Humans; Obesity; Sympathomimetics | 1995 |
Challenges in obesity management.
Topics: 1-Naphthylamine; Adrenergic beta-Agonists; Appetite Depressants; Behavior Therapy; Caffeine; Cyclobutanes; Diethylpropion; Ephedrine; Fenfluramine; Fluoxetine; Humans; Lactones; Leptin; Lipase; Obesity; Orlistat; Phentermine; Proteins; Sertraline | 1998 |
What do pharmacological approaches to obesity management offer? Linking pharmacological mechanisms of obesity management agents to clinical practice.
Topics: Adrenergic beta-Agonists; Animals; Appetite Depressants; Caffeine; Central Nervous System Stimulants; Cyclobutanes; Diet, Reducing; Disease Models, Animal; Energy Intake; Energy Metabolism; Ephedrine; Female; Humans; Life Style; Obesity; Rats; Receptors, Adrenergic, beta; Sympathetic Nervous System; Weight Loss | 1998 |
Drug treatment of obesity.
Topics: Androgen Antagonists; Androgens; Anti-Obesity Agents; Appetite Depressants; Caffeine; Central Nervous System Stimulants; Energy Metabolism; Enzyme Inhibitors; Ephedrine; Humans; Hypoglycemic Agents; Lactones; Lipase; Metformin; Obesity; Orlistat; Patient Selection | 1999 |
Thermogenic drugs as a strategy for treatment of obesity.
Topics: Adrenal Glands; Anti-Obesity Agents; Caffeine; Cyclobutanes; Energy Metabolism; Ephedrine; Humans; Leptin; Obesity; Recombinant Proteins; Sympathetic Nervous System; Thermogenesis | 2000 |
Dietary fat intake, supplements, and weight loss.
Topics: Animals; Anti-Obesity Agents; Aspirin; Carnitine; Citrates; Dietary Fats; Dietary Supplements; Ephedrine; Humans; Insulin; Leptin; Linoleic Acid; Lipid Metabolism; Lipolysis; Mice; Muscle, Skeletal; Obesity; Oxidation-Reduction; Pyruvates; Rats; Triglycerides; Weight Loss; Xanthines | 2000 |
Herbal simulation of ephedrine and caffeine in treatment of obesity.
Topics: Appetite Depressants; Caffeine; Drug Therapy, Combination; Ephedrine; Humans; Obesity; Plant Preparations; Thermogenesis; United States; United States Food and Drug Administration; Weight Loss | 2002 |
Pharmacology of thermogenic drugs.
Topics: Adrenergic beta-Agonists; Body Temperature Regulation; Caffeine; Drug Therapy, Combination; Ephedrine; Humans; Obesity | 1992 |
32 trial(s) available for ephedrine and Obesity
Article | Year |
---|---|
The effect of leptin, caffeine/ephedrine, and their combination upon visceral fat mass and weight loss.
Topics: Absorptiometry, Photon; Adolescent; Adult; Body Composition; Body Weight; Caffeine; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Ephedrine; Female; Humans; Intra-Abdominal Fat; Leptin; Male; Middle Aged; Obesity; Weight Loss; Young Adult | 2013 |
Chronic ephedrine administration decreases brown adipose tissue activity in a randomised controlled human trial: implications for obesity.
Topics: Adipose Tissue, Brown; Blood Glucose; Blood Pressure; Body Composition; Ephedrine; Fluorodeoxyglucose F18; Humans; Male; Obesity; Radionuclide Imaging; Sympathomimetics; Thermogenesis; Young Adult | 2015 |
Ephedrine activates brown adipose tissue in lean but not obese humans.
Topics: Adipose Tissue, Brown; Adrenergic Agents; Adult; Biological Transport; Body Mass Index; Calorimetry, Indirect; Cross-Over Studies; Double-Blind Method; Ephedrine; Fluorodeoxyglucose F18; Glucose; Humans; Male; Multimodal Imaging; Obesity; Positron-Emission Tomography; Sympathomimetics; Thermogenesis; Thinness; Tomography, X-Ray Computed; Young Adult | 2013 |
A randomized double-blind placebo-controlled clinical trial of a product containing ephedrine, caffeine, and other ingredients from herbal sources for treatment of overweight and obesity in the absence of lifestyle treatment.
Topics: Adult; Anti-Obesity Agents; Benzyl Alcohols; Body Mass Index; Caffeine; Cola; Double-Blind Method; Drug Combinations; Ephedra sinica; Ephedrine; Female; Glucosides; Humans; Logistic Models; Male; Middle Aged; Obesity; Phytotherapy; Plants, Medicinal; Salix; Statistics, Nonparametric; Time Factors; Weight Loss | 2004 |
Comparison of the acute pharmacodynamic responses after single doses of ephedrine or sibutramine in healthy, overweight volunteers.
Topics: Adult; Anti-Obesity Agents; Basal Metabolism; Blood Glucose; Blood Pressure; Body Composition; Body Mass Index; Creatinine; Cyclobutanes; Double-Blind Method; Ephedrine; Glycerol; Heart Rate; Humans; Obesity; Triglycerides | 2004 |
Is an ephedrine caffeine treatment contraindicated in hypertension?
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Analysis of Variance; Appetite Depressants; Caffeine; Chi-Square Distribution; Contraindications; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Ephedrine; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Obesity | 1997 |
Combining beta-adrenergic and peroxisome proliferator-activated receptor gamma stimulation improves lipoprotein composition in healthy moderately obese subjects.
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Apolipoproteins; Caffeine; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cyclic AMP; Double-Blind Method; Drug Synergism; Ephedrine; Female; Humans; Hypoglycemic Agents; Lipoproteins; Male; Middle Aged; Obesity; Phosphodiesterase Inhibitors; Pioglitazone; PPAR gamma; Prospective Studies; Thiazolidinediones; Triglycerides; Ultracentrifugation | 2006 |
[Ephedrine in the treatment of obesity. A double-blind cross-over trial of the effect of Elsinore tablets].
Topics: Adult; Aged; Body Weight; Clinical Trials as Topic; Double-Blind Method; Ephedrine; Female; Humans; Male; Middle Aged; Obesity; Prospective Studies; Random Allocation | 1980 |
[Elsinore banting tablets. A controlled clinical trial in general practice].
Topics: Adolescent; Adult; Body Weight; Clinical Trials as Topic; Drug Combinations; Ephedrine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Obesity; Phenobarbital; Random Allocation | 1980 |
[Effect of Elsinore tablets in the treatment of obesity. A controlled clinical trial].
Topics: Adolescent; Adult; Body Weight; Clinical Trials as Topic; Diethylpropion; Double-Blind Method; Ephedrine; Female; Humans; Male; Middle Aged; Obesity; Random Allocation | 1980 |
[Elsinore tablets and ephedrine as slimming agents].
Topics: Adult; Body Weight; Clinical Trials as Topic; Double-Blind Method; Ephedrine; Female; Humans; Male; Obesity; Random Allocation | 1980 |
[Weight loss by treatment with Fugoa depot. Results of a double blind study].
Topics: Aged; Body Weight; Clinical Trials as Topic; Double-Blind Method; Ephedrine; Female; Humans; Male; Middle Aged; Obesity; Phenylpropanolamine; Stereoisomerism | 1980 |
Ephedrine as an anorectic: the story of the 'Elsinore pill'.
Topics: Adolescent; Adult; Appetite Depressants; Caffeine; Diet, Reducing; Diethylpropion; Drug Combinations; Ephedrine; Female; Humans; Male; Middle Aged; Obesity; Placebos | 1981 |
The effect of ephedrine plus caffeine on plasma lipids and lipoproteins during a 4.2 MJ/day diet.
Topics: Body Composition; Caffeine; Cholesterol; Cholesterol, HDL; Diet, Reducing; Double-Blind Method; Ephedrine; Female; Growth Hormone; Humans; Lipids; Obesity; Thyroid Hormones; Triglycerides; Weight Loss | 1994 |
The acute and chronic effects of ephedrine/caffeine mixtures on energy expenditure and glucose metabolism in humans.
Topics: Adult; Blood Glucose; Caffeine; Double-Blind Method; Drug Therapy, Combination; Energy Metabolism; Ephedrine; Female; Humans; Male; Obesity; Substance Withdrawal Syndrome; Weight Loss | 1993 |
Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity. A double-blind multi-centre trial in general practice.
Topics: Adolescent; Adult; Aged; Blood Pressure; Body Mass Index; Caffeine; Double-Blind Method; Ephedrine; Female; Fenfluramine; Heart Rate; Humans; Male; Middle Aged; Obesity; Weight Loss | 1994 |
Safety and efficacy of long-term treatment with ephedrine, caffeine and an ephedrine/caffeine mixture.
Topics: Adult; Blood Pressure; Caffeine; Double-Blind Method; Drug Therapy, Combination; Ephedrine; Female; Humans; Male; Obesity; Placebos; Weight Loss | 1993 |
Ephedrine, caffeine and aspirin: safety and efficacy for treatment of human obesity.
Topics: Adult; Aspirin; Caffeine; Drug Therapy, Combination; Energy Intake; Ephedrine; Female; Humans; Male; Obesity; Weight Loss | 1993 |
Pharmacological and clinical studies of ephedrine and other thermogenic agonists.
Topics: Appetite Depressants; Body Temperature Regulation; Caffeine; Ephedrine; Humans; Obesity; Sympathomimetics | 1995 |
Double-blind, randomized, placebo-controlled clinical trials with non-prescription medications for the treatment of obesity.
Topics: Adolescent; Adult; Aged; Appetite Depressants; Benzocaine; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Ephedrine; Female; Humans; Male; Middle Aged; Nonprescription Drugs; Obesity; Phenylpropanolamine; Weight Loss | 1999 |
Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents.
Topics: Adipose Tissue; Adolescent; Apolipoproteins B; Blood Pressure; Body Composition; Caffeine; Double-Blind Method; Electric Impedance; Energy Intake; Ephedrine; Female; Heart Rate; Humans; Male; Obesity; Placebos; Substance Withdrawal Syndrome; Weight Loss | 2000 |
The effect of an herbal dietary supplement containing ephedrine and caffeine on oxygen consumption in humans.
Topics: Caffeine; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Ephedrine; Female; Humans; Obesity; Oxygen Consumption; Plant Extracts; Weight Loss | 2000 |
Effects of chronic administration of ephedrine during very-low-calorie diets on energy expenditure, protein metabolism and hormone levels in obese subjects.
Topics: Adult; Catecholamines; Diet, Reducing; Double-Blind Method; Drug Administration Schedule; Energy Metabolism; Ephedrine; Female; Humans; Male; Methylhistidines; Middle Aged; Nitrogen; Obesity; Thyroid Hormones; Weight Loss | 1992 |
The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial.
Topics: Administration, Oral; Adult; Analysis of Variance; Blood Pressure; Caffeine; Chemotherapy, Adjuvant; Diet, Reducing; Double-Blind Method; Drug Combinations; Drug Synergism; Energy Intake; Ephedrine; Female; Heart Rate; Humans; Male; Middle Aged; Obesity; Tablets; Weight Loss | 1992 |
Ephedrine and weight loss.
Topics: Ephedrine; Humans; Obesity; Weight Loss | 1992 |
The effect of ephedrine/caffeine mixture on energy expenditure and body composition in obese women.
Topics: Body Composition; Caffeine; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Energy Metabolism; Ephedrine; Female; Humans; Obesity | 1992 |
Effect of anti-obesity drugs promoting energy expenditure, yohimbine and ephedrine, on gastric emptying in obese patients.
Topics: Adult; Double-Blind Method; Energy Metabolism; Ephedrine; Female; Gamma Cameras; Gastric Emptying; Humans; Male; Microspheres; Obesity; Serum Albumin; Technetium; Yohimbine | 1991 |
Ephedrine, caffeine and aspirin promote weight loss in obese subjects.
Topics: Adult; Aspirin; Caffeine; Drug Therapy, Combination; Ephedrine; Female; Humans; Male; Obesity; Weight Loss | 1990 |
Does ephedrine promote weight loss in low-energy-adapted obese women?
Topics: Adult; Body Weight; Clinical Trials as Topic; Diet, Reducing; Double-Blind Method; Energy Metabolism; Ephedrine; Female; Humans; Middle Aged; Obesity; Random Allocation | 1987 |
A controlled trial using ephedrine in the treatment of obesity.
Topics: Caffeine; Clinical Trials as Topic; Drug Combinations; Ephedrine; Humans; Obesity; Theophylline | 1986 |
The thermogenic properties of ephedrine/methylxanthine mixtures: human studies.
Topics: Adult; Basal Metabolism; Body Temperature Regulation; Caffeine; Calorimetry; Disease Susceptibility; Drug Combinations; Energy Metabolism; Ephedrine; Fasting; Female; Food; Humans; Male; Obesity; Theophylline; Xanthines | 1986 |
A controlled trial using ephedrine in the treatment of obesity.
Topics: Adolescent; Adult; Aged; Body Temperature Regulation; Clinical Trials as Topic; Double-Blind Method; Ephedrine; Female; Humans; Male; Middle Aged; Obesity | 1985 |
60 other study(ies) available for ephedrine and Obesity
Article | Year |
---|---|
Therapeutic effects of Gambi-jung for the treatment of obesity.
Topics: 3T3-L1 Cells; Adipose Tissue, White; Adult; Aged; Animals; Anti-Obesity Agents; Appetite Depressants; Body Composition; Body Mass Index; Eating; Ephedra sinica; Ephedrine; Female; Humans; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Middle Aged; Obesity; Plant Extracts; Weight Loss | 2021 |
Cardiolipin profiles as a potential biomarker of mitochondrial health in diet-induced obese mice subjected to exercise, diet-restriction and ephedrine treatment.
Topics: Adipose Tissue, Brown; Animals; Biomarkers; Caloric Restriction; Cardiolipins; Chromatography, Liquid; Diet; Ephedrine; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Microscopy, Electron, Transmission; Mitochondria; Obesity; Physical Conditioning, Animal; Tandem Mass Spectrometry | 2014 |
Treatment of hypothalamic obesity with caffeine and ephedrine.
Topics: Adolescent; Adult; Anti-Obesity Agents; Caffeine; Ephedrine; Female; Humans; Hypothalamic Diseases; Obesity | 2008 |
Responses of brown adipose tissue to diet-induced obesity, exercise, dietary restriction and ephedrine treatment.
Topics: Adipose Tissue, Brown; Animals; Body Composition; Body Weight; Caloric Restriction; Dietary Fats; Energy Metabolism; Ephedrine; Gene Expression; Liver; Male; Mice; Mice, Inbred Strains; Mitochondria, Liver; Mitochondrial Proteins; Motor Activity; Obesity; Oxygen Consumption; Sympathomimetics | 2013 |
[Ephedrine and ephedra in weight loss products and other preparations].
Topics: Adverse Drug Reaction Reporting Systems; Appetite Depressants; Arrhythmias, Cardiac; Caffeine; Central Nervous System Stimulants; Dietary Supplements; Ephedra; Ephedrine; Humans; Netherlands; Obesity; Plant Extracts; Seizures; Weight Loss | 2002 |
[Letigen, insulin resistance and treatment of obesity].
Topics: Appetite Depressants; Caffeine; Ephedrine; Humans; Insulin Resistance; Obesity | 2002 |
[Liberalized use of Letigen--how is the documentation?].
Topics: Adult; Appetite Depressants; Body Mass Index; Caffeine; Central Nervous System Stimulants; Child; Drug Information Services; Ephedrine; Humans; Obesity; Practice Guidelines as Topic | 2002 |
[Letigen, insulin resistance and treatment of obesity--again].
Topics: Appetite Depressants; Caffeine; Central Nervous System Stimulants; Ephedrine; Humans; Insulin Resistance; Obesity | 2002 |
[Obesity epidemic after Letigen].
Topics: Appetite Depressants; Caffeine; Central Nervous System Stimulants; Denmark; Diabetes Mellitus, Type 1; Ephedrine; Evidence-Based Medicine; Humans; Obesity | 2002 |
[Analeptic amines in the therapy of obesity].
Topics: Amines; Central Nervous System Stimulants; Ephedrine; Obesity | 1952 |
[Observations on obesity in amputees].
Topics: Amputation, Surgical; Amputees; Ephedrine; Humans; Obesity | 1955 |
[Experience with autotherapeutic use of vencipon].
Topics: Ephedrine; Humans; Obesity; Phenolphthalein | 1956 |
[Results and observations in long-term treatment of obesity].
Topics: Ephedrine; Humans; Long-Term Care; Obesity; Phenolphthalein | 1956 |
[Notes on therapy of obesity].
Topics: Ephedrine; Humans; Obesity; Vitamin A; Vitamin K; Vitamins | 1957 |
[Vencipon, a new reducing remedy with central nervous effect].
Topics: Ephedrine; Humans; Nerve Tissue; Obesity; Phenolphthalein | 1955 |
Value of ephedrine-ethlenediamine as an appetite depressant: comparison with d-amphetamine sulfate.
Topics: Amphetamine; Amphetamines; Appetite Depressants; Dextroamphetamine; Ephedrine; Ethylenediamines; Obesity | 1960 |
[The anti-obesity agent X112 in the drug scene].
Topics: Adolescent; Adult; Central Nervous System Stimulants; Drug Prescriptions; Ephedrine; Female; Humans; Male; Nicotinic Acids; Nikethamide; Obesity; Plant Extracts; Substance-Related Disorders | 1980 |
Ephedrine, a potential slimming drug, directly stimulates thermogenesis in brown adipocytes via beta-adrenoreceptors.
Topics: Adipose Tissue, Brown; Animals; Body Temperature Regulation; Cells, Cultured; Dose-Response Relationship, Drug; Ephedrine; Female; Norepinephrine; Obesity; Oxygen Consumption; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Stereoisomerism; Stimulation, Chemical | 1982 |
Glycemic response to selected sympathomimetics in stressed normal and goldthioglucose mice.
Topics: Animals; Aurothioglucose; Blood Glucose; Corticosterone; Diabetes Mellitus; Diabetes Mellitus, Experimental; Ephedrine; Male; Mice; Obesity; Phenylephrine; Phenylpropanolamine; Stress, Physiological; Sympathomimetics | 1983 |
Thermogenic drugs for the treatment of obesity: sympathetic stimulants in animal models.
Topics: Animals; Body Temperature Regulation; Body Weight; Disease Models, Animal; Drug Evaluation, Preclinical; Ephedrine; Female; Male; Mice; Mice, Inbred Strains; Mice, Obese; Obesity; Rats; Rats, Zucker; Stimulation, Chemical; Sympathomimetics; Tranylcypromine | 1984 |
Genetically obese C57BL/6 ob/ob mice respond normally to sympathomimetic compounds.
Topics: Adipose Tissue, Brown; Animals; Body Temperature Regulation; Energy Metabolism; Ephedrine; Ethanolamines; Female; Guanosine Diphosphate; Kinetics; Metabolism; Mice; Mice, Inbred C57BL; Mice, Obese; Norepinephrine; Obesity; Propranolol; Sympathomimetics | 1984 |
Thermogenic drugs for the treatment of obesity: screening using obese rats and mice.
Topics: Animals; Body Weight; Eating; Ephedrine; Ethinyl Estradiol; Male; Mice; Mice, Inbred CBA; Obesity; Oxygen Consumption; Rats; Triiodothyronine | 1983 |
Ephedrine reduces weight of viable yellow obese mice (Avy/a).
Topics: Animals; Body Temperature; Body Weight; Eating; Ephedrine; Lipids; Mice; Mice, Inbred Strains; Obesity; Time Factors | 1981 |
Nonparametric analysis of response curves.
Topics: Adult; Animals; Asthma; Behavior, Animal; Blood Glucose; Child; Ephedrine; Humans; Obesity; Peak Expiratory Flow Rate; Phosphates; Random Allocation; Rats; Research Design; Statistics as Topic; Terbutaline | 1980 |
Ephedrine, Xanthines, Aspirin and Other Thermogenic Drugs to Assist the Dietary Management of Obesity. Proceedings of an international symposium. Geneva, 24-26 September 1992.
Topics: Animals; Aspirin; Ephedrine; Humans; Obesity; Xanthines | 1993 |
Ephedrine in the treatment of obesity.
Topics: Ephedrine; Humans; Obesity | 1993 |
Effects of weight loss, ephedrine and aspirin on energy expenditure in obese women.
Topics: Adult; Aspirin; Basal Metabolism; Energy Metabolism; Ephedrine; Exercise; Female; Humans; Obesity; Retrospective Studies; Weight Loss | 1993 |
Effects of ephedrine and aminophylline on resting energy expenditure in obese adolescents.
Topics: Adolescent; Aminophylline; Basal Metabolism; Body Temperature Regulation; Child; Energy Metabolism; Ephedrine; Female; Humans; Male; Obesity | 1993 |
Effect of ephedrine and theophylline on weight loss, resting energy expenditure and lipoprotein lipase activity in obese over-fed rats.
Topics: Animals; Basal Metabolism; Cholesterol; Diet; Energy Intake; Energy Metabolism; Ephedrine; Lipoprotein Lipase; Male; Obesity; Rats; Rats, Wistar; Theophylline; Triglycerides; Weight Loss | 1993 |
Effect of physical training on thermogenic responses to cold and ephedrine in obesity.
Topics: Adult; Analysis of Variance; Basal Metabolism; Body Composition; Body Temperature Regulation; Body Weight; Cold Temperature; Energy Metabolism; Ephedrine; Exercise; Female; Humans; Male; Norepinephrine; Obesity; Oxygen Consumption | 1993 |
Thermogenic, anti-obesity effects of bofu-tsusho-san in MSG-obese mice.
Topics: Adipose Tissue; Animals; Body Composition; Body Temperature Regulation; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Eating; Electron Transport Complex IV; Energy Metabolism; Ephedrine; Female; Glycyrrhiza; Guanosine Diphosphate; Japan; Mice; Mice, Inbred ICR; Mice, Obese; Mitochondria; Obesity; Phosphodiesterase Inhibitors; Plants, Medicinal; Sodium Glutamate; Time Factors | 1995 |
Post-prandial thermogenesis with ephedrine, caffeine and aspirin in lean, pre-disposed obese and obese women.
Topics: Adult; Aspirin; Basal Metabolism; Body Constitution; Body Mass Index; Body Temperature Regulation; Caffeine; Calorimetry, Indirect; Ephedrine; Female; Food; Humans; Kinetics; Obesity | 1996 |
Cardiovascular effects of ephedrine, caffeine and yohimbine measured by thoracic electrical bioimpedance in obese women.
Topics: Adrenergic alpha-Antagonists; Adult; Appetite Depressants; Body Mass Index; Caffeine; Cardiography, Impedance; Central Nervous System Stimulants; Diet, Reducing; Ephedrine; Exercise Test; Female; Hemodynamics; Humans; Obesity; Yohimbine | 1998 |
Energy expenditure, body composition, and glucose metabolism in lean and obese rhesus monkeys treated with ephedrine and caffeine.
Topics: Animals; Blood Glucose; Body Composition; Caffeine; Eating; Energy Metabolism; Ephedrine; Glucose Tolerance Test; Leptin; Macaca mulatta; Male; Obesity; Proteins; Weight Loss | 1998 |
Sudden death after typhoid and Japanese encephalitis vaccination in a young male taking pseudoephedrine.
Topics: Adult; Appetite Depressants; Cause of Death; Death, Sudden; Encephalitis, Japanese; Ephedrine; Exercise; Heat Stress Disorders; Humans; Male; Military Personnel; Obesity; Typhoid-Paratyphoid Vaccines; Viral Vaccines | 1999 |
Pharmaceutical cost savings of treating obesity with weight loss medications.
Topics: Adolescent; Adult; Appetite Depressants; Caffeine; Cardiovascular Diseases; Diabetes Mellitus; Drug Costs; Ephedrine; Female; Fenfluramine; Humans; Hyperlipidemias; Hypertension; Male; Mazindol; Middle Aged; Obesity; Phentermine; Risk Factors; Weight Loss | 1999 |
Green tea and thermogenesis: interactions between catechin-polyphenols, caffeine and sympathetic activity.
Topics: Adipose Tissue, Brown; Animals; Body Temperature Regulation; Caffeine; Catechin; Central Nervous System Stimulants; Culture Techniques; Ephedrine; Flavonoids; Herb-Drug Interactions; Male; Norepinephrine; Obesity; Oxygen Consumption; Phenols; Plant Extracts; Polymers; Rats; Rats, Sprague-Dawley; Sympathectomy; Sympathetic Nervous System; Tea | 2000 |
[The role of pharmacotherapy for treatment of obesity in adults].
Topics: Adult; Animals; Anti-Obesity Agents; Chlorphentermine; Cyclobutanes; Dexfenfluramine; Dopamine Agonists; Ephedrine; Fluoxetine; Humans; Lactones; Mazindol; Obesity; Orlistat | 2000 |
Natural hazards. Tonic or toxic? Americans are gobbling up nature's remedies for everything from obesity to depression.
Topics: Cognition Disorders; Consumer Product Safety; Depression; Dietary Supplements; Ephedrine; Ginkgo biloba; Humans; Hypericum; Obesity; Panax; Phytotherapy; Plants, Medicinal; United States; United States Food and Drug Administration | 2001 |
Acute psychosis due to the interaction of legal compounds--ephedra alkaloids in 'vigueur fit' tablets, caffeine in 'red bull' and alcohol.
Topics: Adult; Alcohol Drinking; Caffeine; Central Nervous System Stimulants; Drug Interactions; Ephedrine; Ethanol; Humans; Male; Obesity; Phytotherapy; Psychoses, Substance-Induced; Substance Abuse Detection; Violence | 2001 |
Safety and efficacy of ephedra and ephedrine for enhancement of athletic performance, thermogenesis and the treatment of obesity.
Topics: Ephedra; Ephedrine; Evidence-Based Medicine; Humans; Obesity; Physical Endurance; Phytotherapy; Thermogenesis | 2002 |
Ephedrine, a thermogenic and potential slimming drug.
Topics: Animals; Body Composition; Eating; Energy Metabolism; Ephedrine; Mice; Mice, Obese; Obesity; Oxygen; Rats | 1977 |
[Mode of action and indication for appetite depressants in the treatment of obesity].
Topics: Amphetamine; Amphetamines; Appetite Depressants; Behavior Therapy; Body Weight; Chemical Phenomena; Chemistry; Diet Therapy; Ephedrine; Humans; Obesity; Physical Exertion; Time Factors | 1975 |
Potentiation of the thermogenic antiobesity effects of ephedrine by dietary methylxanthines: adenosine antagonism or phosphodiesterase inhibition?
Topics: Adenosine; Adipose Tissue, Brown; Animals; Caffeine; Diet; Dose-Response Relationship, Drug; Drug Synergism; Eating; Ephedrine; Fasting; Hot Temperature; Male; Obesity; Oxygen Consumption; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Sympathectomy, Chemical; Theobromine; Xanthines | 1992 |
[Effect of ephedrine on gastric emptying in obese patients].
Topics: Adult; Body Weight; Depression, Chemical; Ephedrine; Female; Gastric Emptying; Humans; Obesity | 1991 |
Aspirin potentiates the effect of ephedrine on the thermogenic response to a meal in obese but not lean women.
Topics: Adult; Analysis of Variance; Anthropometry; Aspirin; Basal Metabolism; Body Temperature Regulation; Drug Synergism; Eating; Ephedrine; Female; Humans; Obesity | 1991 |
Increased metabolic rate in obese women after ingestion of potassium, magnesium- and phosphate-enriched orange juice or injection of ephedrine.
Topics: Adult; Beverages; Body Mass Index; Citrus; Cohort Studies; Drinking; Energy Metabolism; Ephedrine; Female; Heart Rate; Humans; Magnesium; Middle Aged; Obesity; Phosphates; Potassium; Random Allocation; Respiration | 1991 |
Reduced adipsin expression in murine obesity: effect of age and treatment with the sympathomimetic-thermogenic drug mixture ephedrine and caffeine.
Topics: Adipose Tissue, Brown; Aging; Animals; Body Temperature; Caffeine; Complement Factor D; Drug Combinations; Ephedrine; Gene Expression Regulation; Mice; Mice, Inbred Strains; Mice, Mutant Strains; Obesity; RNA, Messenger; Serine Endopeptidases; Sodium Glutamate; Sympathomimetics; Time Factors | 1990 |
Ephedrine-induced thermogenesis as an adjunct to cognitive restructuring and covert conditioning: a proposal for treatment of obese individuals.
Topics: Adipose Tissue; Basal Metabolism; Behavior Therapy; Cognitive Behavioral Therapy; Combined Modality Therapy; Conditioning, Psychological; Ephedrine; Humans; Norepinephrine; Obesity | 1989 |
Caffeine and ephedrine stimulated thermogenesis in LA-corpulent rats.
Topics: Adipose Tissue, Brown; Animals; Body Temperature Regulation; Caffeine; Ephedrine; Female; Obesity; Rats; Rats, Mutant Strains | 1986 |
Thermogenic agents in the treatment of human obesity: preliminary results.
Topics: Adult; Ephedrine; Etilefrine; Female; Humans; Obesity; Phenylephrine | 1987 |
Thermogenesis in human brown adipose tissue and skeletal muscle induced by sympathomimetic stimulation.
Topics: Adipose Tissue, Brown; Adult; Animals; Body Temperature Regulation; Body Weight; Energy Metabolism; Ephedrine; Female; Humans; Lipid Metabolism; Male; Muscles; Norepinephrine; Obesity; Oxidation-Reduction; Oxygen Consumption; Rats; Sympathetic Nervous System; Sympathomimetics | 1986 |
Effects of ephedrine and atenolol on the development of obesity and diabetes in ob/ob mice.
Topics: Aging; Animals; Atenolol; Blood Glucose; Body Weight; Diabetes Mellitus; Diabetes Mellitus, Experimental; Eating; Ephedrine; Insulin; Male; Mice; Mice, Obese; Obesity | 1986 |
Reversal of obesity in the genetically obese fa/fa Zucker rat with an ephedrine/methylxanthines thermogenic mixture.
Topics: Animals; Body Temperature Regulation; Body Weight; Caffeine; Drug Therapy, Combination; Eating; Energy Intake; Energy Metabolism; Ephedrine; Food Deprivation; Male; Obesity; Rats; Rats, Zucker; Theophylline | 1987 |
Aspirin as a promoter of ephedrine-induced thermogenesis: potential use in the treatment of obesity.
Topics: Adipose Tissue; Animals; Aspirin; Body Temperature Regulation; Drug Therapy, Combination; Energy Metabolism; Ephedrine; Mice; Obesity; Oxygen Consumption | 1987 |
Prevention of genetic fa/fa obesity with an ephedrine-methylxanthines thermogenic mixture.
Topics: Animals; Body Composition; Body Temperature Regulation; Caffeine; Energy Intake; Energy Metabolism; Ephedrine; Food Deprivation; Obesity; Rats; Rats, Inbred Strains; Theophylline | 1987 |
The thermogenic properties of ephedrine/methylxanthine mixtures: animal studies.
Topics: Administration, Oral; Animals; Body Composition; Body Weight; Caffeine; Drug Combinations; Energy Metabolism; Ephedrine; Male; Mice; Obesity; Oxygen Consumption; Xanthines | 1986 |
Enhanced thermogenic responsiveness during chronic ephedrine treatment in man.
Topics: Adipose Tissue, Brown; Adolescent; Adult; Blood Glucose; Blood Pressure; Body Temperature Regulation; Body Weight; Catecholamines; Energy Intake; Ephedrine; Fatty Acids, Nonesterified; Female; Heart Rate; Humans; Middle Aged; Obesity; Oxygen Consumption; Potassium; Sodium; Thyroxine; Time Factors; Triiodothyronine | 1985 |
Drugs in obesity.
Topics: Amphetamine; Appetite Depressants; Diet, Reducing; Diuretics; Ephedrine; Fenfluramine; Health Education; Humans; Legislation, Drug; Metformin; Methylcellulose; Motivation; Obesity; Phenformin; Physical Exertion; South Africa; Thyroxine | 1974 |
[Behavior of nonesterified fatty acids during the treatment of obesity with appetite depressants].
Topics: Adolescent; Adult; Appetite Depressants; Ephedrine; Epinephrine; Fatty Acids, Nonesterified; Female; Humans; Male; Middle Aged; Nerve Endings; Norepinephrine; Obesity; Stimulation, Chemical; Time Factors | 1971 |